華森製藥(002907.SZ):收到藥品再註冊批准通知書
格隆匯8月6日丨華森製藥(002907.SZ)公佈,公司於近日收到重慶市藥品監督管理局核准簽發的關於公司1個化學原料藥的《化學原料藥再註冊批准通知書》和2個藥品的《藥品再註冊批准通知書》。
鹽酸戊乙奎醚:原料藥用於生產鹽酸戊乙奎醚注射液。
鹽酸戊乙奎醚注射液:為選擇性抗膽鹼藥。①用於麻醉前給藥以抑制唾液腺和氣道腺體分泌;②用於有機磷毒物(農藥)中毒急救治療和中毒後期或膽鹼酯酶(ChE)老化後維持阿托品化。
鋁碳酸鎂片適應症:①慢性胃炎;②與胃酸有關的胃部不適症狀,如胃痛、胃灼熱感(燒心)、酸性噯氣、飽脹等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.